S-TARget therapeutics was founded in September 2010  as a spin-off of  f-star GmbH and is funded by Grants from INiTS, AWS and FFG. Furthermore, S-TARget received a PRIMOCID grant from  EUROPRIM-Net under EU contractRII3-026155 of the 6th framework program.

PRIMOCID